Research Paper Volume 12, Issue 13 pp 13281—13296

SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer

Figure 4. Prognostic values of differential expressed SLC family members in ovarian cancer (Kaplan–Meier Plotter). (A) Venn diagram for the screening of the genes with both significant differential expression and prognostic value. (BM) Prognostic significance of individual SLC family members with both significant differential expression and prognostic value in ovarian cancer. SLC, solute carrier.